Cardiac Product Articles & Analysis
14 news found
Our lead product is 3D cardiac engineered heart tissues (EHTs) fabricated from human induced pluripotent stem cell (iPSC) derived cardiomyocytes. ...
The studies listed below focus on iRhythm’s core suite of Zio XT and AT patch-based extended and mobile cardiac monitoring products and services. Saturday, Nov. 5 3:00 – 4:00 p.m. ...
(Company or Imricor) (ASX:IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Company has submitted for approval to commence a real-time iCMR-guided ventricular tachycardia (VT) ablation clinical trial. ...
ByImricor
(Company or Imricor) (ASX:IMR) the global leader in Realtime iCMR cardiac ablation products, is pleased to announce it has entered into a Development Agreement with Mammendorfer Institut für Physik und Medizin GmbH (MIPM), a leading developer and manufacturer of MRI-compatible medical devices, including an MRI-compatible external cardioverter defibrillator. ...
ByImricor
(Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, today announced the scheduled retirement of its Chief Financial Officer, Ms Lori Milbrandt, and the appointment of Mr Jonathon Gut as the incoming Chief Financial Officer. ...
ByImricor
(Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the Henry Dunant Hospital Centre in Athens, Greece (https://www.dunant.gr/en/) is the latest institution to adopt Imricor’s iCMR ablation solutions. ...
ByImricor
(Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the German Heart Centre Berlin (https://www.dhzb.de/en/), and the Charité Medical University, Virchow-Klinikum Campus (Charité) (https://www.charite.de/en/), both in Berlin, Germany, are the latest two institutions to adopt ...
ByImricor
Dr Steinhaus has extensive clinical and business experience in cardiac rhythm management, including performing numerous clinical studies in implantable cardiac devices and leads. ...
(Company or Imricor) (ASX:IMR) the global leader in iCMR-guided cardiac ablation products, is pleased to announce that the Semmelweis University Heart and Vascular Centre in Budapest Hungary, has signed a purchase agreement with Imricor, making it the eleventh site to establish an iCMR lab to perform ablations with Imricor’s products. ...
ByImricor
In January, FDA granted Cognito breakthrough device designation for its lead product, for the treatment of cognitive and functional symptoms associated with Alzheimer’s disease. ...
Further work in line with the study presented at the ISHLT conference will enable CorWave to complete the development of its cardiac pump as well as to start production and clinical ...
ByCorWave
Medicomp, Inc., a technology leader in remote and wireless cardiac monitoring, is pleased to announce a strategic partnership with New York based Lenox Hill Hospital, part of the Northwell Health system. ...
Earlier in his career, David was a Senior Principal Scientist at Medtronic where he released products including an implantable cardiac monitor. He holds 12 patents and has published 26 book chapters and papers. ...
The analysis evaluated the outcomes of patients and prognostic value of post-percutaneous coronary intervention (post-PCI) FFR assessment, indicating patients with a lower FFR post-PCI are more likely to experience a major adverse cardiac event (MACE). This registry was developed in collaboration with ACIST Medical Systems, a pioneering interventional and diagnostic technology ...